Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Loh

Showing results (441-450 of 479) with videos related to

Pageof 48
Sort By:
Blood|March 16, 2025
Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcomeChangya Chen, Jason Xu, Jonathan H Sussman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2024
Reply to: Accurate Determinants of Outcome in ALLTi-Cheng Chang, Wenan Chen, Chunxu Qu, et al.
The Lancet. Haematology|February 1, 2023
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trialsSumit Gupta, Yunfeng Dai, Zhiguo Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2024
Genomic Determinants of Outcome in Acute Lymphoblastic LeukemiaTi-Cheng Chang, Wenan Chen, Chunxu Qu, et al.
Leukemia|February 15, 2024
Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group ReportN J DelRocco, M L Loh, M J Borowitz, et al.
Blood|January 27, 2017
Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemiaViktoras Frismantas, Maria Pamela Dobay, Anna Rinaldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2023
Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology GroupKaren R Rabin, Meenakshi Devidas, Zhiguo Chen, et al.
Plos One|June 23, 2021
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibodyConrad E Z Chan, Shirley G K Seah, De Hoe Chye, et al.
Cancer Cell|April 24, 2018
Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic LeukemiaMichelle L Churchman, Maoxiang Qian, Geertruy Te Kronnie, et al.
Blood|April 15, 2017
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology GroupShalini C Reshmi, Richard C Harvey, Kathryn G Roberts, et al.
Pageof 48

Showing results (441-450 of 479) with videos related to

Sort By:
Pageof 48
Blood|March 16, 2025
Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcomeChangya Chen, Jason Xu, Jonathan H Sussman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2024
Reply to: Accurate Determinants of Outcome in ALLTi-Cheng Chang, Wenan Chen, Chunxu Qu, et al.
The Lancet. Haematology|February 1, 2023
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trialsSumit Gupta, Yunfeng Dai, Zhiguo Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2024
Genomic Determinants of Outcome in Acute Lymphoblastic LeukemiaTi-Cheng Chang, Wenan Chen, Chunxu Qu, et al.
Leukemia|February 15, 2024
Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group ReportN J DelRocco, M L Loh, M J Borowitz, et al.
Blood|January 27, 2017
Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemiaViktoras Frismantas, Maria Pamela Dobay, Anna Rinaldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2023
Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology GroupKaren R Rabin, Meenakshi Devidas, Zhiguo Chen, et al.
Plos One|June 23, 2021
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibodyConrad E Z Chan, Shirley G K Seah, De Hoe Chye, et al.
Cancer Cell|April 24, 2018
Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic LeukemiaMichelle L Churchman, Maoxiang Qian, Geertruy Te Kronnie, et al.
Blood|April 15, 2017
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology GroupShalini C Reshmi, Richard C Harvey, Kathryn G Roberts, et al.
Pageof 48